← Back to Search

Nalox-comm Training Module for Naloxone (Nalox-Comm Trial)

N/A
Waitlist Available
Led By Delesha Carpenter, PhD, MSPH
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month period before intervention and 3-month follow-up dispensing data

Summary

This trial tests if training pharmacists on how to talk about naloxone can help them dispense it more effectively and improve patient understanding. The study involves 120 pharmacists and measures their performance over time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month period before intervention and 3-month follow-up dispensing data
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month period before intervention and 3-month follow-up dispensing data for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Naloxone Dispensing Rate Over a 6-month Period
Secondary study objectives
Mean Naloxone Counselling Self-Efficacy Score
Mean Pharmacist Quality of Non-verbal Communication Score
Mean Willingness to Dispense Naloxone Score

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Nalox-CommExperimental Treatment1 Intervention
This is a newly developed 30-60 minute online module focused on teaching pharmacists how to overcome naloxone communication barriers.
Group II: Prescribe to Prevent Naloxone Training ModulePlacebo Group1 Intervention
This a 55-minute online module that covers basic information about naloxone that is relevant to community pharmacists.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nalox-comm Training Module
2021
N/A
~50

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,557 Previous Clinical Trials
4,299,004 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,589 Previous Clinical Trials
3,328,469 Total Patients Enrolled
Delesha Carpenter, PhD, MSPHPrincipal InvestigatorUNC Eshelman School of Pharmacy
~11 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top